A forum for researchers, students and applicants in the field of cyclodextrin technology
Researchers in Japan have developed a promising new drug delivery platform that not only carries medicines directly to bone, but
Professor Arthur Lütringhaus is the pioneer of the chemistry of interlocked supramolecular systems, that he named catenates. Arthur Lüttringhaus (1906-1992)
Glioblastoma (GB) is the most common and aggressive malignant brain tumor, with a median survival of only 12–15 months despite
Researchers in Japan have developed a promising new drug delivery platform that not only carries medicines directly to bone, but
Professor Arthur Lütringhaus is the pioneer of the chemistry of interlocked supramolecular systems, that he named catenates. Arthur Lüttringhaus (1906-1992)
Glioblastoma (GB) is the most common and aggressive malignant brain tumor, with a median survival of only 12–15 months despite
In Scientific Reports, a Japanese team investigated these effects for α-CD derivatives with various replaced substituents from the perspective of
The success story of Cantrixil, a potent anti-cancer drug candidate, has been followed on our blog for years, and now
Oculis’s most advanced product candidate, OCS-01, is currently in Phase 3 development and aims to be the first eye drop
The adsorption of drugs and their carriers onto double-stranded DNA is potentially significant for their transport and release within cells,
In recent decades, the biomedical and pharmaceutical potential of cyclodextrins has expanded remarkably. Their well‑established host–guest complexation ability continues to
A Nanjing, China based research group designed a tailored investigation [1] based on a surprising previous study [2]. In they
Ischemic stroke is a leading cause of mortality and long-term disability worldwide, with limited pharmacological interventions available. Researchers in Arizona
